Koji Takagi,Antoine Kimmoun,Naoki Sato et al.
Koji Takagi et al.
Acute heart failure (AHF), a global pandemic with high morbidity and mortality, exerts a considerable economic burden. AHF includes a broad spectrum of clinical presentations ranging from new-onset heart failure to cardiogenic shock. Key el...
Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure [0.03%]
心力衰竭中的血管紧张素受体-中性肽酶抑制剂(ARNI)疗法
Barry Greenberg
Barry Greenberg
Recognition that neurohormonal activation plays a central role in the pathogenesis of heart failure (HF) led to the development of angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers, mineralocorticoid receptor a...
The Value of Prolonged QRS in Patients with Heart Failure and Cardiogenic Shock [0.03%]
心力衰竭和心脏性休克患者延长QRS波段的价值
Se Yong Jang,Dong Heon Yang
Se Yong Jang
Grace Casaclang-Verzosa
Grace Casaclang-Verzosa
Rate of Rehospitalization in 60 Days of Discharge and It's Determinants in Patients with Heart Failure with Reduced Ejection Fraction in a Tertiary Care Centre in India [0.03%]
印度三级医疗中心射血分数降低的心力衰竭患者的再住院率及其决定因素
Kakasaheb H Bhosale,Ranjit Kumar Nath,Neeraj Pandit et al.
Kakasaheb H Bhosale et al.
Background and objectives: Identifying the patients with acute heart failure (HF) at high risk for rehospitalization after hospital discharge will enable proper optimization of treatment. This study is aimed to evaluate t...
Prognostic Value of QRS Duration among Patients with Cardiogenic Shock Complicating Acute Heart Failure: Data from the Korean Acute Heart Failure (KorAHF) Registry [0.03%]
QRS波间期对心源性休克型急性心衰患者预后的影响：来自韩国急性心衰注册登记(KorAHF)的数据分析
Jung Ae Hong,Min-Seok Kim,Hanbit Park et al.
Jung Ae Hong et al.
Background and objectives: Prolonged QRS duration is associated with poor outcomes in patients with chronic heart failure (HF). However, the prognostic value of QRS duration in patients with cardiogenic shock complicating...
COVID-19 - Implications for Patients with Heart Failure: The Korean Society of Heart Failure's Clinical Recommendations [0.03%]
COVID-19对心力衰竭患者的影响：韩国心力衰竭学会的临床建议
Dong-Hyuk Cho,Byung-Su Yoo,Jung-Woo Son et al.
Dong-Hyuk Cho et al.
Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction [0.03%]
螺内酯在心力衰竭和左室射血分数改善患者中停药的合理性和研究设计
Junho Hyun,Sang Eun Lee,Seung-Ah Lee et al.
Junho Hyun et al.
It is unclear if guideline-directed medical therapy (GDMT) should be maintained in patients who have heart failure (HF) with improved ejection fraction (HFiEF). Of the medications recommended for HF, mineralocorticoid receptor antagonist (M...
Remote Patient Monitoring in Heart Failure: Factors for Clinical Efficacy [0.03%]
远程患者监控在心力衰竭治疗中的临床疗效因素分析
Ankit Bhatia,Thomas M Maddox
Ankit Bhatia
Despite clinical advances in its treatment, heart failure (HF) is associated with significant adverse clinical outcomes and is among the greatest drivers of healthcare utilization. Outpatient management of HF remains suboptimal, with gaps i...